The Patient Perspective
Benefit from the real-world experience of fellow patients and caregivers as they share what they learned from participating in clinical trials.
For in-depth information visit these important articles
CAR T-Cell Therapy Trial at UCLA Health Did What Years of Other Treatments Could Not for a Non-Hodgkin Lymphoma (NHL) Survivor
CAR T-cell therapy trial at UCLA Health did what years of other treatments couldn’t for a non-Hodgkin lymphoma (NHL) survivor
On March 22, 2018, I was an outpatient at the Seattle Cancer Care Alliance where I was transfused with my own T-cells that had been harvested a few weeks earlier, then genetically reengineered to attack my cancer, multiplied manyfold, then reinjected into my bloodstream to rest up, grow again, and
Watch Mark’s video in which he talks about his clinical trial experience, MRD testing, and how he achieved uMRD.
By Julia Walsh – Patient When I was diagnosed in 2013, my treatment options were limited. I saw a community hematology-oncology doctor who told me that I would likely receive FCR, or chemotherapy, as my first line of treatment. And he was correct – the new targeted inhibitors like ibrutinib
By Doug Olson – Patient My name is Doug Olson and I am a CLL survivor with a rather unique story to tell. It is truly a privilege to have an opportunity to share my journey with CLL with all of you who visit this wonderful web site. However,
By Linda Brandt Myers – Patient ITHACA, N.Y. In May 1994, on the eve of my marriage to my husband, Sandy, I was diagnosed with chronic lymphocytic leukemia (CLL). I remember hearing my oncologist tell me I had ten years to live (what he actually said was more like: “The
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.